Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas

被引:0
|
作者
Abramovich, CM [1 ]
Prayson, RA [1 ]
机构
[1] Cleveland Clin Fdn, Dept Anat Pathol L25, Cleveland, OH 44195 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background.-Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. Design.-This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test. Results.-The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P = .024) and nuclear pleomorphism (P < .001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0-32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 ils was noted between the initially excised recurrent tumor and the most recently resected recurrence. Conclusions.-Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 50 条
  • [1] Histopathologic features and MIB-1 labeling indices (L1) in recurrent versus non-recurrent meningiomas.
    Abramovich, CM
    Prayson, RA
    MODERN PATHOLOGY, 1998, 11 (01) : 158A - 158A
  • [2] MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors
    Abramovich, CM
    Prayson, RA
    HUMAN PATHOLOGY, 1998, 29 (12) : 1420 - 1427
  • [3] Interobserver variability in determining MIB-1 labeling indices
    Prayson, RA
    Castilla, E
    Hembury, T
    Liu, W
    Noga, C
    Prok, A
    MODERN PATHOLOGY, 2002, 15 (01) : 333A - 333A
  • [4] Interobserver variability in determining MIB-1 labeling indices
    Prayson, RA
    Castilla, E
    Hembury, T
    Liu, W
    Noga, C
    Prok, A
    LABORATORY INVESTIGATION, 2002, 82 (01) : 333A - 333A
  • [5] Histologic features and MIB-1/Ki67 indices in atypical meningiomas (GII WHO)
    Jozefowicz, Mateusz
    Papierz, Wielislaw
    AKTUALNOSCI NEUROLOGICZNE, 2012, 12 (02): : 104 - 128
  • [6] Prognostic significance of MIB-1 labeling indices for oligodendroglial tumors
    Abacioglu, U
    Sengoz, M
    Tezcanli, E
    Akpulat, S
    Peker, S
    Sav, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 122S - 122S
  • [7] Significance of MIB-1 staining indices in meningiomas - Comparison of two counting methods
    Nakasu, S
    Li, DH
    Okabe, H
    Nakajima, M
    Matsuda, M
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (04) : 472 - 478
  • [8] FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas
    Wach, Johannes
    Lampmann, Tim
    Gueresir, Agi
    Schuss, Patrick
    Vatter, Hartmut
    Herrlinger, Ulrich
    Becker, Albert
    Hoelzel, Michael
    Toma, Marieta
    Gueresir, Erdem
    CANCERS, 2021, 13 (14)
  • [9] Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas
    Langford, LA
    Cooksley, CS
    DeMonte, F
    HUMAN PATHOLOGY, 1996, 27 (04) : 350 - 354
  • [10] MIB-1 staining index of pediatric meningiomas
    Sandberg, DI
    Edgar, MA
    Resch, L
    Rutka, JT
    Becker, LE
    Souweidane, MM
    NEUROSURGERY, 2001, 48 (03) : 590 - 595